Key Benefits (from Clinical Trials) Phase 2 clinical trials have shown promising, dose-dependent results when used alongside diet and exercise: Significant Weight Loss: Participants on the highest dose (12 mg) lost up to 24.2% of their body weight over 48 weeks, a result that surpasses current approved medications like Mounjaro and Wegovy in trial comparisons
We dont have data to be able to back up what were doing clinically, Batsis says
Retatrutide is an investigational medication that activates three hormone receptors simultaneously to promote significant weight loss, improve blood sugar levels, and enhance metabolic function
Understanding GLP-1 Microdosing: A New Approach to Metabolic Health This content is for educational purposes only and does not constitute medical advice
Recommendations: A Collaborative Approach If you are considering or currently taking a GLP-1 inhibitor, especially if you have a pre-existing mental health condition, open communication with both your prescribing physician and your mental health provider is paramount
A comprehensive multivitamin provides baseline coverage for multiple nutrients but typically contains insufficient amounts of B12 for someone experiencing deficiency